Skip to main content

Table 3 Molecular pathological characteristics in two groups

From: Monitored anesthesia care and asleep-awake-asleep techniques combined with multiple monitoring for resection of gliomas in eloquent brain areas: a retrospective analysis of 225 patients

 

MAC (%)

AAA (%)

p-value

IDH mutation

 Yes

56 (30.4)

7 (17.1)

0.795

 No

77 (41.8)

11 (26.8)

 

Lost to follow-up

51 (27.7)

23 (56.1)

 

MGMT promoter methylation

 Yes

46 (25.0)

14 (34.1)

0.553

 No

83 (45.1)

20 (48.8)

 

Lost to follow-up

55 (29.9)

7 (17.1)

 

ki67 proliferation index

23.46 ± 21.34

165 (89.7)

24.38 ± 19.91

34 (82.9)

0.817

Lost to follow-up

19 (10.3)

7 (17.1)

 

Deficient for both 1p and 19q

 Yes

28 (15.2)

1 (2.4)

0.392

 No

81 (44.0)

10 (24.4)

 

Lost to follow-up

75 (40.8)

30 (73.2)

 
  1. MAC monitored anesthesia care group
  2. AAA asleep-awake-asleep group